Regulatory
FDA rejects two new dietary ingredient submissions for CBD, leaving hemp industry with legislation as only route to clarity
RegulatoryFDA rejects two new dietary ingredient submissions for CBD, leaving hemp industry with legislation as only route to clarityFDA rejects two new dietary ingredient submissions for CBD, leaving hemp industry with legislation as only route to clarity
The FDA has rejected NDI submissions from Charlotte's Web and Irwin Naturals and the agency's objections suggest regulators have little interest in approving CBD without legislative guidance.
Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.